Literature DB >> 20955830

Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.

Jodi K Craigo1, Shannon Barnes, Sheila J Cook, Charles J Issel, Ronald C Montelaro.   

Abstract

We recently reported an attenuated EIAV vaccine study that directly examined the effect of lentiviral envelope sequence variation on vaccine efficacy. The study [1] demonstrated for the first time the failure of an ancestral vaccine to protect and revealed a significant, inverse, linear relationship between envelope divergence and protection from disease. In the current study we examine in detail the evolution of the attenuated vaccine strain utilized in this previous study. We demonstrate here that the attenuated strain progressively evolved during the six-month pre-challenge period and that the observed protection from disease was significantly associated with divergence from the original vaccine strain.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955830      PMCID: PMC2997116          DOI: 10.1016/j.vaccine.2010.10.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  62 in total

1.  Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.

Authors:  S A Hammond; F Li; B M McKeon; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  Live attenuated HIV vaccines: a proposal for further research and development.

Authors:  J Mills; R Desrosiers; E Rud; N Almond
Journal:  AIDS Res Hum Retroviruses       Date:  2000-10-10       Impact factor: 2.205

Review 3.  Developments in preclinical AIDS vaccine efficacy models.

Authors:  W M Bogers; C Cheng-Mayer; R C Montelaro
Journal:  AIDS       Date:  2000       Impact factor: 4.177

4.  Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV).

Authors:  R Frank Cook; S J Cook; F Li Li; R C Montelaro; C J Issel
Journal:  J Virol Methods       Date:  2002-08       Impact factor: 2.014

5.  The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.

Authors:  F Li; C Leroux; J K Craigo; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Mechanism of protection of live attenuated simian immunodeficiency virus: coevolution of viral and immune responses.

Authors:  George B Cohen
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

7.  Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety.

Authors:  S M Blower; K Koelle; D E Kirschner; J Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

8.  Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.

Authors:  C Leroux; J K Craigo; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques.

Authors:  J Münch; N Stolte; D Fuchs; C Stahl-Hennig; F Kirchhoff
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.

Authors:  Jodi K Craigo; Caroline Leroux; Laryssa Howe; Jonathan D Steckbeck; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

View more
  12 in total

1.  Antibody escape kinetics of equine infectious anemia virus infection of horses.

Authors:  Elissa J Schwartz; Seema Nanda; Robert H Mealey
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

2.  EQUINE INFECTIOUS ANEMIA VIRUS INFECTION AND IMMUNITY: LESSONS FOR AIDS VACCINE DEVELOPMENT.

Authors:  Jodi K Craigo; Ronald C Montelaro
Journal:  Future Virol       Date:  2011-02       Impact factor: 1.831

3.  Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Authors:  Jodi K Craigo; Corin Ezzelarab; Ronald C Montelaro
Journal:  J Virol Methods       Date:  2012-07-20       Impact factor: 2.014

4.  Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.

Authors:  Diana T Cervantes; Judith M Ball; John Edwards; Susan Payne
Journal:  Virus Genes       Date:  2016-01-06       Impact factor: 2.332

5.  Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Authors:  Chong Liu; Sheila J Cook; Jodi K Craigo; Frank R Cook; Charles J Issel; Ronald C Montelaro; David W Horohov
Journal:  Vet Immunol Immunopathol       Date:  2014-08-10       Impact factor: 2.046

Review 6.  Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.

Authors:  Jodi K Craigo; Ronald C Montelaro
Journal:  Viruses       Date:  2013-12-02       Impact factor: 5.048

7.  Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain.

Authors:  Jiansen Du; Xuefeng Wang; Jing Ma; Jianxin Wang; Yuyin Qin; Chunhui Zhu; Fang Liu; Yiming Shao; Jianhua Zhou; Wentao Qiao; Xinqi Liu
Journal:  Retrovirology       Date:  2014-03-21       Impact factor: 4.602

8.  Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Chong Liu; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

9.  Envelope determinants of equine lentiviral vaccine protection.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Liu Chong; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 10.  Immunization against small ruminant lentiviruses.

Authors:  Ramsés Reina; Damián de Andrés; Beatriz Amorena
Journal:  Viruses       Date:  2013-08-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.